Rare cancer: ovarian clear cell carcinoma
Connect with others with ovarian clear cell carcinoma
Interested in more discussions like this? Go to the Gynecologic Cancers Support Group.
Connect with others with ovarian clear cell carcinoma
Interested in more discussions like this? Go to the Gynecologic Cancers Support Group.
Definitely save those hair accessories!
My hair grew back in a mop and I had it shaped up into a short style about 5 months after my last chemo. For whatever it’s worth, I kept it short and ditched the hair dryer & straightener. Very freeing and a time saver as well.
-
Like -
Helpful -
Hug
4 ReactionsChemo is kind of awful = but for most of us being alive is so worth it! Hard decisions.
-
Like -
Helpful -
Hug
1 ReactionThis is great news for many women with aggressive cancers. Sadly, my biomarker report card says that I’m proficient, but maybe there will soon be something equally hopeful for me and my sisters soon.
-
Like -
Helpful -
Hug
2 ReactionsThank you so very much for the clarification. I want to get on Herceptin/trastuzumab because my HER 2 score is 3+ , the worst. Insurance wouldn't approve it and won't until other treatments have proved useless. Right now I have "mixed results." My oncologist tried hard to get it for me, and also appealed to the drug company for compassionate freebie, but no luck. The justification for denial is that it isn't yet approved for uterine cancer - just breast cancer. I have Untited Health Medicare. Would love to hear from others if you got approved for Herceptin/trastuzumab with your insurance, and what insurance you have. Maybe I could use that to make an appeal. "All these other companies approve it, so join the club." I haven't seen PD-1 on my lab report. I'll look again. There is a study on using Ivermectin against PD one at Cedar Sinai in LA . Not sure how it worked out. Any know anything about Ivermectin use? It doesn't cost much so there isn't any incentive for drug companies to spend a lot of dollars to study it. No return on investment. If I'm pMMR how does that connect with PD -1, if at all?
-
Like -
Helpful -
Hug
2 Reactionsive got basic medicare w aarp medigap g. love it. basically if medicare approves it, medigap pays the copay. basic medicare has no maximum out of pocket which is VERY bad but the additional medigap does. have to get your own drug policy tho
-
Like -
Helpful -
Hug
3 ReactionsThank you! My doc said something about a cousin drug to Traszumabab that I could take if the chemo I'm on doesn't work. I bet this is it. Wish I didn't have to wait. I'll ask her about Enhertu.
-
Like -
Helpful -
Hug
1 Reactionthanks, i read reports of the study on jemperli and wanted to switch to it. asked my oncologist plus the second opinion doc at mayo phoenix. apparently i am pMMR though so they thought Herceptin was the better of the two. i was very impressed with the study results, however. the thing that bothers me is that i've had two medical people say, from looking at a very bad pre-surgery CT-scan and a clean one done post-fifth infusion, that it is obvious that the chemo is working. that seems like very bad logic - it seems to me that it means that either the surgery or the chemo is working. seems bad for them to base a treatment plan on bad logic. unless if i hadn't had the chemo, i would have metastasized by the second ct-scan BUT THEN WHY DIDN'T THEY SAY THAT WHEN I WAS TRYING TO DECIDE ON WHETHER TO DO CHEMO OR NOT????? these doctors are shifty little creatures -- JUST GIVE ME THE DATA!
-
Like -
Helpful -
Hug
1 ReactionCan I ask some questions to clarify what's going on? In one of your earlier posts, I think you said that your cancer was stage 4B. Is that right? That would mean that in the scan before your surgery, there would have been metastatic cancer outside of where they were going to operate. Right? Do you know where that was? Presumably that was not removed in your surgery? And did the report from the scan after some chemo say that those tumors had shrunk or disappeared? Do you have the radiology reports? They're usually pretty detailed about things like that.
At the two hospitals where I've had scans done, they also provide a link to the actual scans, which I find interesting to look through, although I'm not very good at spotting the cancer. But they often circle the tumors (in just one of the thousands of sections), so you can see what they're looking at.
I'm not a doctor, but from my perspective, it sounds like you're getting treatment that is better than standard of care, since you're getting the Herceptin.
-
Like -
Helpful -
Hug
1 ReactionHere's an explanation of how anti-PD-1 drugs work. It's probably TMI.
PD-1 is a protein found on the surface of immune cells (not cancer cells). When the immune cell is in position to kill a target cell, PD-1 can bind to a protein on the surface of the target cell called PD-L1 and this prevents the killing. So expressing PD-L1 is one way that cancer cells escape killing by the immune system. Keytruda, Jemperli, and several similar drugs prevent the PD-1 to PD-L1 interaction and restore killing of cancer cells by immune cells.
But there's something else needed for the immune system to want to kill the cancer cells in the first place. It has to recognize the cancer cells as abnormal. The main way this happens is because the cancer has mutations, some of which cause it to make abnormal proteins. The immune system can detect these abnormal proteins.
Some cancers have thousands of mutations and so make thousands of abnormal proteins that can generate an immune response. Other cancers only have a few mutations. So using Keytruda etc. to unleash the immune system works much, much better on cancers with lots of mutations. Cancers that are defective in the DNA repair process called mismatch repair (MMR) have lots of mutations. So do cancers with mutations in the gene POLE, as well as melanomas (which have uv-induced mutations) and lung cancers, particularly in smokers. So Keytruda etc can have dramatic effects on these cancers.
Endometrial cancers that are proficient in MMR (pMMR) tend not to have many mutations, so there's not a high likelihood of a major response to Keytruda or Jemperli. They do give them to people anyway, since there is a modest improvement in prognosis with them.
-
Like -
Helpful -
Hug
5 ReactionsThank you so very very much. Not TMI at all. Just the right amount, clearly stated.
I have "mixed response," to treatment - one tumor shrinking, new ones appearing. This helps explain why. I am pMMR . Because of the way insurance works, I have to go through this step to get what I hope might be more helpful - something that will address my HER2 score of 3+.
-
Like -
Helpful -
Hug
1 Reaction